A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Clinical trial NCT02514551 · COMPLETED
Trial details
- NCT number
- NCT02514551
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-12
- Primary completion
- 2017-10-27
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.